NICOLE DUNNIGAN: Open Payments
NPI 1578349619 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,800 in 272 payments from 15 companies in 2025. Trend: 2023 $217 · 2024 $4,079 · 2025 $3,800
Food & beverage: $3,771Education: $29
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $502 |
| Vanda Pharmaceuticals Inc. | 26 | $496 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $437 |
| Otsuka America Pharmaceutical, Inc. | 38 | $422 |
| E.R. Squibb & Sons, L.L.C. | 18 | $347 |
| ABBVIE INC. | 33 | $338 |
| Janssen Pharmaceuticals, Inc | 14 | $250 |
| Lundbeck LLC | 14 | $243 |
| Axsome Therapeutics, Inc. | 12 | $167 |
| Teva Pharmaceuticals USA, Inc. | 26 | $164 |
Products named: REXULTI, ARISTADA, CAPLYTA, COBENFY, VRAYLAR, HETLIOZ, FANAPT, Auvelity.
Industry payments across NC — which companies pay providers there.
